November 22, 2013
A
common excuse that entrepreneurs make for not being able to innovate is
the lack of venture capital in their region. They argue that because
investors are not ready to take a risk, they can’t succeed. Policy makers all over the world make the same excuse. So did legendary Indian entrepreneur Kiran Mazumdar-Shaw in a Linkedin post about “why India can’t produce a single Apple or a Google”.
Access
to venture capital may have been a problem as recently as a decade ago,
but is no longer an inhibitor. The cost of developing world-changing
startups has dropped dramatically. With the exponential advances in
technologies such as computing, storage, and sensors, entrepreneurs can
do what only governments and big research labs could do before: solve
big problems.
When Google was founded in 1998, for example, the
DEC AlphaServer 8400, a minicomputer with the same processing power the
iPad enjoys today, cost close to $1 million. Storage necessitated
installing a server farm and rack upon rack of hard disks. It cost
millions of dollars to start a technology company. Today, anyone can buy
computing power and storage for practically nothing from companies such
as Amazon and Google. The iPhone 5S is more powerful than the Cray
supercomputers of yesteryear—which the U.S. placed tight export
restrictions on. Today we carry supercomputers in our pockets and use
them to check e-mail and make phone calls every now and then.
It
cost more than a billion dollars to sequence a full human genome a
decade ago. It costs less than three thousand dollars to do now. Soon it
will cost less than a cup of coffee. Genome data are available from
millions of people already; soon this will be in the billions. Anyone
anywhere can now write computer code that compares one person’s DNA with
another; learn what diseases people with similar genes have had; and
analyze the correspondences between genomes and the effectiveness with
which different medications or other interventions have treated a given
disease.
The same advances are happening with sensor-based
devices. Sensors such as those in our iPhones cost tens of thousands of
dollars a few years ago but now cost practically nothing. They are
allowing us to build devices to monitor our health—so that we can
prevent disease and dramatically reduce health-care costs. Entrepreneurs
are building iPhone apps that act like medical assistants and detect
disease; smart pills that we swallow in order to monitor our internals;
and body sensors that monitor heart, brain, and body activity. Sensors
are also being used to monitor soil humidity, pressure in oil pipelines,
and traffic patterns. These are available to Indian entrepreneurs as
readily as to scientists in U.S. research labs.
One device that I recently tested is by Alivecor.
The prototype that Alivecor gave me worked with India’s $40 Aakash
tablet. It provides the same information as expensive EKG machines do,
and the data can be uploaded to the cloud and analyzed by software.
An entrepreneur I know in Chile also built a water sanitization system
that can help reduce the incidence of disease caused by waterborne
viruses in the developing world as well as in the developed world.
Alfredo Zolezzi’s $500 Plasma Water Sanitation System
does what even the most expensive water sanitization systems
don’t—kills 100% of the bacteria and viruses in water. This device can
help save the millions of lives that are lost because of unsanitary
water. It could also earn billions in revenue. Zolezzi built this with a
small team in Chile—with no venture capital.
Students I have
mentored at Singularity University also came up with some amazing
advances. Here are some examples of what they are building—without
venture capital. (You can watch videos of from these students here.)
Matternet.
One team built a drone-based transportation system that can deliver
medicine, food, goods, and supplies to wherever they are needed. This is
particularly applicable to parts of Africa, where roads either don’t
exist or get washed away. (Watch this TED Talk to learn more.)
MirOculus. Another
team designed and tested a device and method that detect cancer at an
early stage, quickly and at low cost, by using microRNA fingerprinting
to screen for multiple types of cancer in a single blood test. This
paves the way toward a new era in which microRNAs serve as cancer
biomarkers.
Lifestock. What if we
could “3D print” real meat, slaughter-free, to feed the 21st century,
one team asked. The team prototyped a new method for synthetically
producing meat that cost 1/40 of current culture methods.
BluBox.
Imagine of you could use discarded DVD players to do blood tests and
the results were instant. That is what this team did—build a $100 lab on
a DVD player. Anyone will be able to do complex tests at home using
these devices when they become commercially available.
So, Kiran,
there are no more excuses. All it takes to build an innovation ecosystem
is determined entrepreneurs, experienced and helpful mentors, and a
government and society that encourage experimentation and risk-taking. I
know that India—and many other regions can provide these ingredients.
Aucun commentaire:
Enregistrer un commentaire
Remarque : Seul un membre de ce blog est autorisé à enregistrer un commentaire.